Catalyst
Slingshot members are tracking this event:
Phase 3 trial of AXS-02 for Complex regional pain syndrome (CRPS) expected to be completed by end of 2017 - Discontinued
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AXSM | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2018
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=254022&p=irol-newsArticle&ID=2325661
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Trial, Axs-02, Complex Regional Pain Syndrome, Crps
